Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Hepatobiliary System and PancreasDRG 433-cirrhosis-and-alcoholic-hepatitis-with-cc
    Ask Trek AI about this page

    Cirrhosis and Alcoholic Hepatitis with CC: Inpatient Reimbursement Overview

    DRG 433 encompasses inpatient admissions for cirrhosis and alcoholic hepatitis with a Complication or Comorbidity, reflecting greater clinical complexity than cases without such comorbid conditions. Proper Classification affects Medicare inpatient reimbursement because the presence of a Complication or Comorbidity increases resource intensity and influences payment weight.

    Customize your policy alerts

    Sign up for drg 433 policy alerts

    Get alerted when payer policies referencing 433 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 433 Overview

    DRG 433 covers inpatient stays for patients with cirrhosis and alcoholic hepatitis when a Complication or Comorbidity is present. This Diagnosis-Related Group captures cases with increased clinical complexity that typically require additional resources such as extended monitoring, management of hepatic decompensation, and treatment of alcohol-related organ dysfunction. It matters for Medicare payment because the presence of Complication or Comorbidity influences relative payment weight and reimbursement for hospitals. Accurate coding of the underlying liver disease, alcoholic hepatitis, and associated Complication or Comorbidity is essential for proper Classification and payment.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute management randomized or observational studies assessing interventions to prevent or treat complications of cirrhosis (for example, management strategies for variceal bleeding, hepatic encephalopathy, spontaneous bacterial peritonitis, or acute alcoholic hepatitis). These trials enroll inpatients with decompensated cirrhosis or acute alcoholic hepatitis to compare immediate clinical protocols, dosing strategies, or supportive care bundles and measure short-term outcomes such as control of bleeding, resolution of encephalopathy, infection clearance, length of ICU/hospital stay, and in-hospital mortality. Results directly inform inpatient care pathways, resource utilization, and complication-related costs that are central to reimbursement and DRG-level performance metrics.
    • Comparative effectiveness and safety studies of cirrhosis complication prevention and management across care settings, including head-to-head evaluations of diagnostic-therapeutic approaches (for example, timing and use of endoscopy, paracentesis strategies, prophylactic antibiotics, or lactulose vs alternative encephalopathy management). These studies typically enroll broader cohorts of patients with compensated and decompensated cirrhosis or those hospitalized with alcoholic hepatitis to determine which approaches reduce readmissions, complications, and downstream procedures. Findings are relevant to hospital clinicians and payers because they affect care protocols, utilization patterns, length of stay, and readmission rates that influence DRG costs and quality measures.
    • Post-discharge and longitudinal outcomes studies, including transitional care interventions, readmission reduction programs, and health services research on long-term survival, transplant referral patterns, and health-related quality of life after hospitalization for cirrhosis or alcoholic hepatitis. These observational cohorts and pragmatic trials follow patients after discharge to evaluate the impact of discharge planning, outpatient monitoring, substance use treatment linkage, and palliative care integration on 30- and 90-day readmissions, emergency visits, and total cost of care. This research is crucial for payers and hospital systems seeking to lower readmission penalties, allocate post-acute resources effectively, and improve value-based outcomes for patients in this DRG.

    Related Codes

    405-PANCREAS-LIVER-AND-SHUNT-PROCEDURES-WITH-MCC

    Pancreas, Liver and Shunt Procedures with MCC: Inpatient Reimbursement Overview

    406-PANCREAS-LIVER-AND-SHUNT-PROCEDURES-WITH-CC

    Pancreas, Liver and Shunt Procedures with CC: Inpatient Reimbursement Overview

    407-PANCREAS-LIVER-AND-SHUNT-PROCEDURES-WITHOUT-CC-MCC

    Pancreas, Liver and Shunt Procedures without CC/MCC: Inpatient Reimbursement Overview

    408-BILIARY-TRACT-PROCEDURES-EXCEPT-ONLY-CHOLECYSTECTOMY-WITH-OR-WITHOUT-C-D-E-WITH-MCC

    Biliary Tract Procedures Except Only Cholecystectomy with or without C.D.E. with MCC: Inpatient Reimbursement Overview

    409-BILIARY-TRACT-PROCEDURES-EXCEPT-ONLY-CHOLECYSTECTOMY-WITH-OR-WITHOUT-C-D-E-WITH-CC

    Biliary Tract Procedures Except Only Cholecystectomy with or without C.D.E. with CC: Inpatient Reimbursement Overview

    410-BILIARY-TRACT-PROCEDURES-EXCEPT-ONLY-CHOLECYSTECTOMY-WITH-OR-WITHOUT-C-D-E-WITHOUT-CC-MCC

    Biliary Tract Procedures Except Only Cholecystectomy with or without C.D.E.: Inpatient Reimbursement Overview

    411-CHOLECYSTECTOMY-WITH-C-D-E-WITH-MCC

    Cholecystectomy with C.D.E. with MCC: Inpatient Reimbursement Overview

    412-CHOLECYSTECTOMY-WITH-C-D-E-WITH-CC

    Cholecystectomy with Common Duct Exploration with Complication or Comorbidity: Inpatient Reimbursement Overview

    413-CHOLECYSTECTOMY-WITH-C-D-E-WITHOUT-CC-MCC

    Cholecystectomy with C.D.E. without CC/MCC: Inpatient Reimbursement Overview

    414-CHOLECYSTECTOMY-EXCEPT-BY-LAPAROSCOPE-WITHOUT-C-D-E-WITH-MCC

    Cholecystectomy Except by Laparoscope without C.D.E. with MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 35

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.